A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular CarcinomaLipika Goyal, Andrew X. Zhu, Thomas A. Abrams et al.|Clinical Cancer Research|2018Cited by 82